Vaccines

The booster shot side effects have been found to closely mirror those of the second dose. According to a recent CDC study, the majority of side effects were mild in nature with arm soreness, fatigue, and headache as the most commonly reported symptoms. Since mid-August, nearly 2.8 million…

This past week the CDC released a report that found the coronavirus vaccines do not increase the risk of birth defects or miscarriages. The study was done on a total of 1,613 pregnant women who were all inoculated with the coronavirus vaccine. The majority of those in the study (70%) were…

People that are eligible for a booster shot have received their second dose of the Pfizer vaccine at least six months ago and fall within one or more of the three high risk groups: 1. 65 years old or older  2. have a medical condition that puts them at a high risk of severe illness with Covid such…

Los Angeles has recently extended its first deadline from Sept. 7 to Sept. 13, and still thousands of city workers have not provided vaccination proof or filed exemption requests on religious or medical grounds. Out of 57,476 city workers the data shows 5,183 have requested religious exemptions,…

Even though tens of millions of Americans continue to decline even the first COVID-19 vaccine every single day, a small but growing number have already sought out additional shots despite the Food and Drug Administration lack of approval. It still remains unclear who exactly needs one and what does…

Moderna announced this week that they are working on a two-in-one vaccine that would combine their covid vaccine with a flu shot currently under development. The new shot, called mRNA-1073, would hopefully increase convenience for individuals who plan on receiving a booster shot. The company hopes…

Over the past few months, Pfizer has been conducting vaccine trials in hopes of acquiring emergency use authorization of their vaccine for children from ages 5 to 11. Pfizer hopes to file their paperwork this month using data from the vaccine trials they have been conducting on younger children.…

Currently, adolescents as young as 12 years old can be vaccinated against COVID-19, but vaccines are still unavailable for children who are younger. One of the major reasons that a vaccine for younger children is taking this long is the lack of data. Hundreds of millions of adults have been…

The COVID-19 vaccines have proven that they are still extremely effective at preventing severe infection but the highly infectious Delta variant of SARS-CoV-2 continues to ravage much of the globe, highlighting the limits of our vaccines. As a result, policymakers and scientists are arguing over…

Studies have shown that effectiveness of the vaccine against COVID-19 has been declining as time passes, thus the main COVID-19 vaccines within the U.S.

As schools and businesses are opening back for in-person businesses, there are still many who hesitate to receive the vaccination shot.

Now that the nation has opened up vaccines for the general public and vaccine companies have produced optimistic news about the safety of vaccines in adolescents and children, Pfizer has began to develop a new form of treatment. Their new treatment, currently in Phase 1, is an oral pill used to…

Almost 130 million Americans, 18 or older, have received at least one dose of the vaccine. As the states are grappling to distribute the vaccines in an efficient and timely manner, there have been extensive maneuver made to undermine the efforts to end the pandemic. Multiple listings on eBay offer…

Many are hopeful to return to "normal" life this coming fall, especially since the eligibility for vaccines are opening up to the general adult population on April 15th. Yet, COVID-19 variants are on the rise and many are fearing the vaccine will not be enough. Thus, a global strategy of "maximum…